Viewing Study NCT02534818


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-03-03 @ 12:03 AM
Study NCT ID: NCT02534818
Status: UNKNOWN
Last Update Posted: 2015-11-10
First Post: 2015-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Different Fluorescein Sodium Dosage for the Detection of Gastric Intestinal Metaplasia
Sponsor: Shandong University
Organization:

Study Overview

Official Title: Conventional Fluorescein Sodium Dosage o.1ml/kg Compared With a Lower Fluorescein Sodium Dosage o.02ml/kg for the Detection of Gastric Intestinal Metaplasia in a High Risk Population: a Randomized Controlled Trial
Status: UNKNOWN
Status Verified Date: 2015-08
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to assess whether lower fluorescein sodium dosage can perceive the same detection rate per patient and per lesion for the detection of gastric intestinal metaplasia.
Detailed Description: Gastric intestinal metaplasia is regarded as an important premalignant lesion for intestinal type gastric cancer. Currently, the histological assessment of gastric intestinal metaplasia still relies on the biopsies took from five sites that the updated Sydney System recommended.

This study aims to compare the diagnostic yield of gastric intestinal metaplasia from two different fluorescein sodium dosage and assess whether lower fluorescein sodium dosage can perceive the same detection rate per patient and per lesion for the detection of gastric intestinal metaplasia.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: